Bemiparin sodium in prevention of tromboembolic complications in gynecological practices

Cover Page

Cite item

Full Text

Abstract

The patients with complicated surgical diseases are relating to the group of high risk of nascence of vein thrombosis and tromboembolism. Aim of the study: to measure of the anticoagulant abilities of bemiparin sodium among women were operated by laparoscopic access in gynecological practices. Materials and methods. 15 women who had been operated for multiple uterine fibroid were examined and enrolled in the basic group. The patients were administered bemiparin sodium 3500 IE (0.2 ml) injected subcutaneously in 6 hours after operative treatment, then once a day during 7 days for prevention of tromboembolic complications in the postoperative period. The control group included 10 healthy women. The following parameters were defined for the control of efficiency of using of bemiparin sodium, his influence on different components of the haemostatic system: D-dimer, thrombocytes quantity and level of fibrinogen. Results. The significant elevation of level of D-dimer and fibrinogen was discovered among patients of the basic group during the preoperative period (p<0.05). The values of indicators of D-dimer and fibrinogen significantly decreased after therapy by bemiparin sodium. It was matched for the values in the control group. Conclusion. The using of bemiparin sodium in the postoperative period proved the high antitrombotic activity and the low risk of developing of bleeding.

About the authors

T A Gustovarova

Smolensk State Medical University of the Ministry of Health of the Russian Federation

Email: tanya.prof@yandex.ru
д-р мед. наук, проф. каф. акушерства и гинекологии 214019, Russian Federation, Smolensk, ul. Krupskoi, d. 28

L S Kirakosyan

Smolensk State Medical University of the Ministry of Health of the Russian Federation

канд. мед. наук, доц. каф. акушерства и гинекологии 214019, Russian Federation, Smolensk, ul. Krupskoi, d. 28

E E Feramusova

Smolensk State Medical University of the Ministry of Health of the Russian Federation

заочный аспирант каф. акушерства и гинекологии 214019, Russian Federation, Smolensk, ul. Krupskoi, d. 28

References

  1. Духин А.О. Профилактика венозных тромбоэмболических осложнений при хирургическом лечении пациенток с гинекологическими заболеваниями. Лечащий врач. 2014; 3: 48-51
  2. Каиров Г.Т. Диагностика, лечение и профилактика тромбозов и тромбоэмболий. Под ред. Г.Т.Каирова. Томск, 2011; с. 33-6
  3. Gonzalez M.J. Clinical experience with bemiparin and new reseach lines. Prog Revof Ven Thromboembol Dis 2007; p. 262-341.
  4. Вирхов Р. Развалины Трои. Исторический вестник. 1880; 1 (2): 415-30
  5. Стуров Н.В. Использование бемипарина в качестве средства профилактики венозных тромбозов в общей хирургии и оперативной онкологии. Трудный пациент. 2012; 10 (12): 16-20.
  6. Kakkar W, Howes J, Sharma V, Kadziola Z. A comparative, doubleblind, randomized trial of a new-second generation LMWH (Bemiparin) and UFH in the prevention of post-operative venous thromboembolism in patients undergoing hip arthroplasty. Thromb Haemost 2000; 83: 523-9.
  7. Клинические рекомендации (протоколы лечения). Профилактика тромбоэмболических синдромов. М.: Стандарт информ, 2015.
  8. Ferruccio De Lorenzo et al. Am Heart J 2002; 143: e3.
  9. Шиффман Ф.Д. Патофизиология крови. Пер. с англ. М., 2000; 191-82.
  10. Moreno González E, Fontcuberta J, de la Llama F. Prophylaxis of thromboembolic disease with RO-11 (ROVI), during abdominal surgery. Hepatogastroenterology 1996; 43: 744-7.
  11. Martínez-González J, Vila L, Rodríguez C. Bemiparin: second-generation, low-molecular-weight heparin for treatment and prophylaxis of venous thromboembolism. Expert Rev Cardiovasc Ther 2008; 6 (6): 793-802.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2018 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).